B7x (B7-H4/B7S1/VTCN1), for example, is an inhibitory immune checkpoint molecule and is considered a potential therapeutic target because of its immunosuppressive effects and well-known expression in cancers (157). The gene discussed is VTCN1; the disease is cancer.